Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    21-February-2001      
Issue 52 * Next Update - 14:00 UTC 08:00 EST    22-February-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 21-February-2001:

The following stories appear in full on Today's Vidyya Medical News Service Web site.

Radiant Medical, Inc. announced the world's first treatment of a heart attack patient with cool therapy. The patient was enrolled in an ongoing clinical trial, COOL MI, designed to investigate the feasibility of cool therapy in heart attack patients. The experimental procedure is intended to reduce the injury caused by a heart attack by reducing the heart's need for oxygen and preventing cell death.

For more information: Cool Therapy Used To Treat Myocardial Infarction

Occasionally, Vidyya comes across an item of controversy that seems like something in which our readers might have an interest. This is the case with http://www.watercure.com, where according to F. Batmanghelidj, MD, the cause of much pain and suffering is dehydration. According to Dr. Batmanghelidj, dehydration is at the root of a host of conditions from hypertension to lupus. Fact or fiction? We at Vidyya don't know, but we thought our readers might like to make up their own minds.

For more information: The Water Cure: Bad Medicine Or Miracle?

Purple grape juice appears unique in its potential ability to provide a beneficial effect to a variety of cardiovascular functions. According to preliminary research by a University of Scranton professor, the fruit of the grapevine appears to bear powerful antioxidant qualities that may improve the body's healthy cardiovascular function.

For more information: The Power Of Grape Juice

The Endometriosis Association is launching a series of new campaigns to educate the public, health care providers and the news media. The cornerstone of the new programs will be free, year-round physician screenings for endometriosis.

For more information: March Is Endometriosis Awareness Month

The February issue of Urology, a respected peer-reviewed specialty journal, carries a paper detailing a successful Phase 2 study demonstrating the safety and efficacy of Topiglan®, MachroChem's topical drug for erectile dysfunction (ED). The company has filed the results of this study with the U.S. Food & Drug Administration, and is now in a phase 3 pivotal trial to support an application for marketing approval.

For more information: Topical Cream For Erectile Dysfunction Successfully Completes Phase II Clinical Studies

Today's Vidyya articles are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.